11，Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipopr otein E type 4 allele and the risk of Alzheimer's disease in late onset families . Science, 1993, 261(5123):921
22，Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: hi gh-avidity binding to beta-amyloid and increased frequency of type 4 allele in l ate-onset familial Alzheimer disease. Proc Natl Acad Sci USA, 1993, 90(5):1977
33，Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apoli poprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's d isease. Neurology, 1993, 43(8):1467
44，Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipop rotein E type 2 allele for late-onset Alzheimer disease. Nat Genet, 1994, 7(2):1 80
55，Van Duijn CM,de Knijff P,Wehnert A,et al.The apolipoprotein E epsilon 2 allele is associated with an increased risk of early-onset Alzheimer's disease a nd a reduced survival.Ann Neurol,1995,37(5):605
66，Talbot C, Lendon C, Craddock N, et al. Protection against Alzheimer's disease with APOE ε2.Lancet, 1994, 343(8910):1432
77，Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethn icity on the association between apolipoprotein E genotype and Alzheimer disease : a meta-analysis. APOE and Altheimer Disease Meta Analysis Consortium. JAMA, 19 97, 278(16):1349
88，Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apol ipoprotein E to synthetic amyloid beta peptide:isoform-specific effects and impl ications for late-onset Alzheimer disease. Proc Natl Acad Sci USA, 1993, 90(17 ):8098
99，Gearing M, Schneider JA, Robbins RS, et al. Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease. J Neuropatho l Exp Neurol, 1995, 54(6):833
1010，Huang DY, Weisgraber KH, Goedert M, et al. ApoE3 binding to tau tande m repeat Ⅰ is abolished by tau serine 262 phosphorylation. Neurosci Lett, 1995, 192(3):209
8[4]Gomez-is LST,West HL Rebeck W,et al.Clinical and pathological correlates of apoliprotein Eε4 In Alzheimer's disease[J].Ann Neurol,1996,39:62-70.
9[6]Josephs K.A,Jsuboi Y,Cookson N,et al.Apolipoprotein eε4 is a determinant for Alzheimer.type pathologic features in tauopathies,synucleinopathies and frontotemporal[J].Clinical Neurology.2005,1(3):0238.
10[11]Yao J,Petanceska SS,Montine TJ,et al.Aging,gender and ApoE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits[J].J Neurochem2004,90(4):1011-8.
